Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model
Neonatal abstinence syndrome (NAS) refers to cadre of withdrawal manifestations in infants born to mothers who used illicit and licit substances during pregnancy. The increasing prevalence of NAS has been largely due to the maternal use of opioids during pregnancy. NAS contributes to increased morbi...
Saved in:
Main Authors: | Thitinart Sithisarn (Author), Sandra J. Legan (Author), Philip M. Westgate (Author), Henrietta S. Bada (Author), Melinda E. Wilson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity
by: Jennifer S. Miller, et al.
Published: (2024) -
Plasma Brain-Derived Neurotrophic Factor Levels in Newborn Infants with Neonatal Abstinence Syndrome
by: Lochan Subedi, et al.
Published: (2017) -
The Effects of Perinatal Oxycodone Exposure on Behavioral Outcome in a Rodent Model
by: Thitinart Sithisarn, et al.
Published: (2017) -
Neonatal Abstinence Syndrome Due to Opioid Abuse in Pregnancy
by: Banu Mutlu Ozyurt, et al.
Published: (2018) -
Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence
by: Gary B. Kaplan, et al.
Published: (2023)